NewsRx

Search our medical news database

The World-Wide Group

255 East 74th Street Defies Market Conditions as It Readies Final Units for Sale

Published in Law and Health Weekly, February 27th, 2010

Savvy buyers should take note: there are only a select number of units left at 255 East 74th Street, as sales continue to outpace the current real estate market in New York City. Condos at the 76-unit super luxury residence on the Upper East Side are more than 90-percent sold according to The World-Wide Group, the project's developer.

"The outstanding success of 255 East 74th Street is a result of its design, location and the appetite today's buyers have for quality and a sound investment," said Richard Lebow, Director of Marketing and Sales for The World-Wide Group. "255 East 74th Street offers buyers large family rooms, interior playrooms, and kitchens that match...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook